April 1, 2026Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided
「日本皮膚科学会 皮膚医学研究基金（ロート製薬寄付）」の受領者が決定しました | 研究開発 | ロート製薬株式会社
Publisher
Japan
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
「日本皮膚科学会 皮膚医学研究基金（ロート製薬寄付）」の受領者が決定しました | 研究開発 | ロート製薬株式会社
Source route
Continue on rohto.co.jp
Leave the platform to read the original full article on the publisher site.
Source: Rohto Pharmaceutical
Scope: Industry
Related coverage
More related coverage
Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026
Shionogi Completes Acquisition of All Rights to RADICAVA (edaravone)
Apr 2, 2026How Us2.ai and Merge Are Bringing AI Echo Directly Into Clinical WorkflowsRepresentatives from Us2.ai and Merge sat down with the Cardiac Wire Show to discuss their new integration and what it means for the echo techs and cardiologists who use it everyday. Together, the two...
Lilly’s Announcement Regarding Oral GLP-1 Foundayo™ (Orforglipron)
TOKYO, April 2, 2026 -- Chugai Pharmaceutical Co., Ltd. (hereafter “Chugai”, TOKYO: 4519) announced...